Forward Uses Technology to Enhance Experience at Doctor's Office
Forward is all about proactive versus reactive healthcare and at the center of it is founder and CEO Adrian Aoun. He joins Alyssa Julya Smith at Forward's Los Angeles location to talk about some of the benefits of Forward and how technology is being used to help with preventative healthcare.
He explains that Tesla's and iPhone's can predict when they're likely to break down and intervene to fix things before it happens and that should be the same with healthcare. Forward created
personalized health plans through an in-depth understanding of a person's genetics, blood test results, biomarkers and daily lifestyle.
Aoun also explains that Forward doesn't use insurance, but is based on a monthly membership cost that allows Forward to do full diagnostic tests without hidden fees or bills from blood work or other lab testing, explaining that it's all done in the office.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
